Our recent studies on this strain of mice revealed that BRCA1 deficiency triggers alterations in multiple events, including mutations in potential tumor metastasis suppressors, an altered epithelial-mesenchymal transition, impaired mitophagy, and increased inflammasome activation, all of which may promote mammary tumor metastasis (11–13). This evidence concerns the gene BRCA1 and neoplasm.